Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency

Elizabeth Hernberg-Ståhl, Anton Luger, Roger Abs, Bengt Åke Bengtsson, Ulla Feldt-Rasmussen, Patrick Wilton, Björn Westberg, John P. Monson, H. Fideleff, H. Burger, A. Luger, R. Abs, V. Hana, U. Feldt-Rasmussen, F. Minuto, S. W. Kim, H. P F Koppeschaar, T. Schreiner, A. Lewinski, M. M A RuasA. Sanmarti, P. Kann, N. Thalassinos, M. Góth, C. Thompson, B. Å Bengtsson, R. C. Gaillard, L. T. Ho, J. P. Monson

Research output: Contribution to journalArticle

63 Citations (Scopus)

Abstract

The morbidity associated with GH deficiency (GHD) in adults is now well established. Furthermore, many controlled clinical trials have demonstrated the efficacy of GH replacement therapy. The aim of the present study was to determine whether the effects of GH replacement in adults are reflected in a reduced use of healthcare resources, in addition to improving quality of life (QoL). Data concerning visits to the doctor, number of days in hospital, and amount of sick leave were obtained from patients included in KIMS (Pharmacia International Metabolic Database), a large pharmacoepidemiological survey of hypopituitary adults with GHD, for 6 months before GH treatment and for 6-12 months after the start of treatment. Assistance required with normal daily activities was recorded at baseline and after 12 months of GH therapy. QoL (assessed using a disease-specific questionnaire, QoL-Assessment of GHD in Adults) and satisfaction with physical activity during leisure time were also assessed. For the total group (n = 304), visits to the doctor, number of days in hospital, and amount of sick leave decreased significantly (P <0.05) after 12 months of GH therapy. Patients also needed less assistance with daily activities, although this was significant (P <0.01) only for the men. QoL improved after 12 months of GH treatment (P <0.001), and both the amount of physical activity and the patients' satisfaction with their level of physical activity improved after 12 months (P <0.001). In conclusion, GH replacement therapy, in previously untreated adults with GHD, produces significant decreases in the use of healthcare resources, which are correlated with improvements in QoL.

Original languageEnglish
Pages (from-to)5277-5281
Number of pages5
JournalJournal of Clinical Endocrinology and Metabolism
Volume86
Issue number11
DOIs
Publication statusPublished - 2001

Fingerprint

Quality of Life
Delivery of Health Care
Sick Leave
Exercise
Therapeutics
Leisure Activities
Controlled Clinical Trials
Patient Satisfaction
Databases
Morbidity
Surveys and Questionnaires

ASJC Scopus subject areas

  • Biochemistry
  • Endocrinology, Diabetes and Metabolism

Cite this

Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. / Hernberg-Ståhl, Elizabeth; Luger, Anton; Abs, Roger; Bengtsson, Bengt Åke; Feldt-Rasmussen, Ulla; Wilton, Patrick; Westberg, Björn; Monson, John P.; Fideleff, H.; Burger, H.; Luger, A.; Abs, R.; Hana, V.; Feldt-Rasmussen, U.; Minuto, F.; Kim, S. W.; Koppeschaar, H. P F; Schreiner, T.; Lewinski, A.; Ruas, M. M A; Sanmarti, A.; Kann, P.; Thalassinos, N.; Góth, M.; Thompson, C.; Bengtsson, B. Å; Gaillard, R. C.; Ho, L. T.; Monson, J. P.

In: Journal of Clinical Endocrinology and Metabolism, Vol. 86, No. 11, 2001, p. 5277-5281.

Research output: Contribution to journalArticle

Hernberg-Ståhl, E, Luger, A, Abs, R, Bengtsson, BÅ, Feldt-Rasmussen, U, Wilton, P, Westberg, B, Monson, JP, Fideleff, H, Burger, H, Luger, A, Abs, R, Hana, V, Feldt-Rasmussen, U, Minuto, F, Kim, SW, Koppeschaar, HPF, Schreiner, T, Lewinski, A, Ruas, MMA, Sanmarti, A, Kann, P, Thalassinos, N, Góth, M, Thompson, C, Bengtsson, BÅ, Gaillard, RC, Ho, LT & Monson, JP 2001, 'Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency', Journal of Clinical Endocrinology and Metabolism, vol. 86, no. 11, pp. 5277-5281. https://doi.org/10.1210/jc.86.11.5277
Hernberg-Ståhl, Elizabeth ; Luger, Anton ; Abs, Roger ; Bengtsson, Bengt Åke ; Feldt-Rasmussen, Ulla ; Wilton, Patrick ; Westberg, Björn ; Monson, John P. ; Fideleff, H. ; Burger, H. ; Luger, A. ; Abs, R. ; Hana, V. ; Feldt-Rasmussen, U. ; Minuto, F. ; Kim, S. W. ; Koppeschaar, H. P F ; Schreiner, T. ; Lewinski, A. ; Ruas, M. M A ; Sanmarti, A. ; Kann, P. ; Thalassinos, N. ; Góth, M. ; Thompson, C. ; Bengtsson, B. Å ; Gaillard, R. C. ; Ho, L. T. ; Monson, J. P. / Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency. In: Journal of Clinical Endocrinology and Metabolism. 2001 ; Vol. 86, No. 11. pp. 5277-5281.
@article{700380ed571042f7a24794a1b6181ec1,
title = "Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency",
abstract = "The morbidity associated with GH deficiency (GHD) in adults is now well established. Furthermore, many controlled clinical trials have demonstrated the efficacy of GH replacement therapy. The aim of the present study was to determine whether the effects of GH replacement in adults are reflected in a reduced use of healthcare resources, in addition to improving quality of life (QoL). Data concerning visits to the doctor, number of days in hospital, and amount of sick leave were obtained from patients included in KIMS (Pharmacia International Metabolic Database), a large pharmacoepidemiological survey of hypopituitary adults with GHD, for 6 months before GH treatment and for 6-12 months after the start of treatment. Assistance required with normal daily activities was recorded at baseline and after 12 months of GH therapy. QoL (assessed using a disease-specific questionnaire, QoL-Assessment of GHD in Adults) and satisfaction with physical activity during leisure time were also assessed. For the total group (n = 304), visits to the doctor, number of days in hospital, and amount of sick leave decreased significantly (P <0.05) after 12 months of GH therapy. Patients also needed less assistance with daily activities, although this was significant (P <0.01) only for the men. QoL improved after 12 months of GH treatment (P <0.001), and both the amount of physical activity and the patients' satisfaction with their level of physical activity improved after 12 months (P <0.001). In conclusion, GH replacement therapy, in previously untreated adults with GHD, produces significant decreases in the use of healthcare resources, which are correlated with improvements in QoL.",
author = "Elizabeth Hernberg-St{\aa}hl and Anton Luger and Roger Abs and Bengtsson, {Bengt {\AA}ke} and Ulla Feldt-Rasmussen and Patrick Wilton and Bj{\"o}rn Westberg and Monson, {John P.} and H. Fideleff and H. Burger and A. Luger and R. Abs and V. Hana and U. Feldt-Rasmussen and F. Minuto and Kim, {S. W.} and Koppeschaar, {H. P F} and T. Schreiner and A. Lewinski and Ruas, {M. M A} and A. Sanmarti and P. Kann and N. Thalassinos and M. G{\'o}th and C. Thompson and Bengtsson, {B. {\AA}} and Gaillard, {R. C.} and Ho, {L. T.} and Monson, {J. P.}",
year = "2001",
doi = "10.1210/jc.86.11.5277",
language = "English",
volume = "86",
pages = "5277--5281",
journal = "Journal of Clinical Endocrinology and Metabolism",
issn = "0021-972X",
publisher = "The Endocrine Society",
number = "11",

}

TY - JOUR

T1 - Healthcare consumption decreases in parallel with improvements in quality of life during GH replacement in hypopituitary adults with GH deficiency

AU - Hernberg-Ståhl, Elizabeth

AU - Luger, Anton

AU - Abs, Roger

AU - Bengtsson, Bengt Åke

AU - Feldt-Rasmussen, Ulla

AU - Wilton, Patrick

AU - Westberg, Björn

AU - Monson, John P.

AU - Fideleff, H.

AU - Burger, H.

AU - Luger, A.

AU - Abs, R.

AU - Hana, V.

AU - Feldt-Rasmussen, U.

AU - Minuto, F.

AU - Kim, S. W.

AU - Koppeschaar, H. P F

AU - Schreiner, T.

AU - Lewinski, A.

AU - Ruas, M. M A

AU - Sanmarti, A.

AU - Kann, P.

AU - Thalassinos, N.

AU - Góth, M.

AU - Thompson, C.

AU - Bengtsson, B. Å

AU - Gaillard, R. C.

AU - Ho, L. T.

AU - Monson, J. P.

PY - 2001

Y1 - 2001

N2 - The morbidity associated with GH deficiency (GHD) in adults is now well established. Furthermore, many controlled clinical trials have demonstrated the efficacy of GH replacement therapy. The aim of the present study was to determine whether the effects of GH replacement in adults are reflected in a reduced use of healthcare resources, in addition to improving quality of life (QoL). Data concerning visits to the doctor, number of days in hospital, and amount of sick leave were obtained from patients included in KIMS (Pharmacia International Metabolic Database), a large pharmacoepidemiological survey of hypopituitary adults with GHD, for 6 months before GH treatment and for 6-12 months after the start of treatment. Assistance required with normal daily activities was recorded at baseline and after 12 months of GH therapy. QoL (assessed using a disease-specific questionnaire, QoL-Assessment of GHD in Adults) and satisfaction with physical activity during leisure time were also assessed. For the total group (n = 304), visits to the doctor, number of days in hospital, and amount of sick leave decreased significantly (P <0.05) after 12 months of GH therapy. Patients also needed less assistance with daily activities, although this was significant (P <0.01) only for the men. QoL improved after 12 months of GH treatment (P <0.001), and both the amount of physical activity and the patients' satisfaction with their level of physical activity improved after 12 months (P <0.001). In conclusion, GH replacement therapy, in previously untreated adults with GHD, produces significant decreases in the use of healthcare resources, which are correlated with improvements in QoL.

AB - The morbidity associated with GH deficiency (GHD) in adults is now well established. Furthermore, many controlled clinical trials have demonstrated the efficacy of GH replacement therapy. The aim of the present study was to determine whether the effects of GH replacement in adults are reflected in a reduced use of healthcare resources, in addition to improving quality of life (QoL). Data concerning visits to the doctor, number of days in hospital, and amount of sick leave were obtained from patients included in KIMS (Pharmacia International Metabolic Database), a large pharmacoepidemiological survey of hypopituitary adults with GHD, for 6 months before GH treatment and for 6-12 months after the start of treatment. Assistance required with normal daily activities was recorded at baseline and after 12 months of GH therapy. QoL (assessed using a disease-specific questionnaire, QoL-Assessment of GHD in Adults) and satisfaction with physical activity during leisure time were also assessed. For the total group (n = 304), visits to the doctor, number of days in hospital, and amount of sick leave decreased significantly (P <0.05) after 12 months of GH therapy. Patients also needed less assistance with daily activities, although this was significant (P <0.01) only for the men. QoL improved after 12 months of GH treatment (P <0.001), and both the amount of physical activity and the patients' satisfaction with their level of physical activity improved after 12 months (P <0.001). In conclusion, GH replacement therapy, in previously untreated adults with GHD, produces significant decreases in the use of healthcare resources, which are correlated with improvements in QoL.

UR - http://www.scopus.com/inward/record.url?scp=17944381371&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=17944381371&partnerID=8YFLogxK

U2 - 10.1210/jc.86.11.5277

DO - 10.1210/jc.86.11.5277

M3 - Article

C2 - 11701692

AN - SCOPUS:17944381371

VL - 86

SP - 5277

EP - 5281

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 11

ER -